Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers
机构:[1]1 Department of Respiratory and Critical Care Medicine, Xinqiao Hospital, The Army Medical University, Chongqing 400037, China[2]Department of Pathology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang District, Luzhou, Sichuan Province 646000, China[3]The First Clinical Institute, Zunyi Medical University, Zunyi, Guizhou Province 563003, China[4]Department of Human Anatomy, School of Basic Medical Sciences, Southwest Medical University, No. 1, Section 1, Xianglin Road, Matan Long District, Luzhou, Sichuan Province 646000, China
Sichuan Science and Technology Support Project (2022YFS0636) and Luzhou Science and Technology Support Project(2022-SYF-39 ) .
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|2 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]1 Department of Respiratory and Critical Care Medicine, Xinqiao Hospital, The Army Medical University, Chongqing 400037, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Kun,Zhao Qi,Dai Xinzhi,et al.Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers[J].Cancer Cell International.2024,24(1):191.doi:10.1186/s12935-024-03371-9.
APA:
Zhao Kun,Zhao Qi,Dai Xinzhi,Wen Xue,Luo Xing...&Dai Qiong.(2024).Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers.Cancer Cell International,24,(1)
MLA:
Zhao Kun,et al."Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers".Cancer Cell International 24..1(2024):191